Serious Liver Injury Being Observed In Patients Without Cirrhosis Taking Ocaliva to Treat Primary Biliary Cholangitis

FDA is notifying health care professionals and patients of this new safety information, and that frequent liver test monitoring is necessary to identify worsening liver function and ensure appropriate discontinuation of Ocaliva.